Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina.
Pfizer Inc applied to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus. | Video
Medical device maker Becton Dickinson and Co said on Thursday it expects as much as $1.5 billion in sales from its COVID-19 diagnostic test next year, after reporting a quarterly profit that beat Wall Street estimates.
Health insurer Humana Inc said on Tuesday it sees a boost to its 2021 profit from strong growth in its Medicare Advantage health plans.
AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday. | Video
Nearly 300,000 more people have died in the United States in 2020 during the coronavirus pandemic than would be expected based on historical trends, with at least two-thirds due to COVID-19, a government report released on Tuesday showed, adding that COVID deaths likely were undercounted. | Video
Nearly 300,000 more people have died in the United States in 2020 during the coronavirus pandemic than expected based on historical trends, with about two-thirds of the deaths due to COVID-19 illnesses, according to a report released on Tuesday. | Video